Insmed Inc (INSM)

[coinstarz]

Normally, a drug company keeps drug price from the public. The detailed revealing of Increlex pricing may have negative impact to TRCA PPS because Investors know that TRCA will not make a good profit from its drug, so why bother? Almost 50-80% of profits (Increlex) go to CBM and DNA, I really don't know how TRCA can make money to support 90 employees. They don't have R&D, no plant, no pipeline, but they do have blood sucker lawyers. I think TRCA's PR is very bad and sad. I am happy iPlex price is high and makes profits.